Rempex Pharmaceuticals Lands $67,500,000 Series B Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8154feb5-eb19-41d2-9011-f61b15b6c79e&Preview=1 - Date
11/9/2011 - Company Name
Rempex Pharmaceuticals - Mailing Address
11535 Sorrento Valley Rd. San Diego, CA 92121 - Company Description
Rempex Pharmaceuticals, Inc. is a biopharmaceutical company whose mission is to develop important new therapies to combat the growing issue of antibiotic resistance. - Website
http://www.rempexpharma.com - Transaction Type
Venture Equity - Transaction Amount
$67,500,000 - Transaction Round
Series B - Proceeds Purposes
This financing gives us the resources to rapidly advance our development programs towards commercialization at a time when the need for new treatments for resistant gram-negative infections has become critical. - M&A Terms
- Venture Investor
Frazier Healthcare Ventures - Venture Investor
Vivo Ventures - Venture Investor
SV Life Sciences - Venture Investor
OrbiMed - Venture Investor
Adams Street Partners
